BMC MAT Quick Start

500+
Downloads
Content rating
Everyone
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image

About this app

Access the most up-to-date evidence-based recommendations for the treatment of opioid use disorder with buprenorphine and naltrexone. Information on OUD treatment with methadone and pain management strategies also reviewed.

Of the more than 22 million people in the United States with a substance use disorder, less than 20% receive any treatment for their substance use. Providing office-based addiction treatment increases access to critical care and saves lives.

We’ve developed this guidance to help inform clinicians on the use of medications for opioid use disorder. Interactive clinical algorithms walk you through each step of the clinical decision-making process to help you care for these patients.

This app is designed exclusively for the use of health care providers. This app is not intended for use to diagnose disease or to cure, mitigate, treat, or prevent any condition or disease. It is the responsibility of the treating clinician to rely on their own experience and knowledge about their specific patient to determine dosages and the best treatment for that patient.
Updated on
Mar 10, 2021

Data safety

Developers can show information here about how their app collects and uses your data. Learn more about data safety
No information available

What's new

Guidelines for office-based addiction treatment at your fingertips. Access the most up-to-date evidence-based recommendations for the treatment of opioid use disorder with buprenorphine and naltrexone.